Results 161 to 170 of about 84,715 (301)

Heart failure in two male patients with late‐onset Fabry mutation (IVS4 + 919G > A)

ESC Heart Failure, Volume 12, Issue 2, Page 1508-1513, April 2025.
Xufei Yang, Chunlan Deng, Xiaogang Guo, Hui Yan   +3 more
wiley   +1 more source

Alogliptin Reduces Oxidative Stress in Cardiomyocytes and Ameliorates Diabetic Cardiomyopathy via the AURKB/NLGN2 Signaling

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT Diabetic cardiomyopathy (DCM) is a common complication of diabetes mellitus. This study investigated the effects of alogliptin on DCM and its underlying mechanisms. A DCM model was constructed and treated with alogliptin. Downstream targets of alogliptin were screened using bioinformatics analysis.
Li‐Jing Jiao, Jing Zhou, Jing Wang, Si‐Nan Zhao, Zhan‐Sheng Zhao, Qian Wang, Ya‐Nan Xie, Wei Jiao   +7 more
wiley   +1 more source

Safety and effect of topical neostigmine ophthalmic solution in animal models. [PDF]

Sci Rep
Ongprakobkul C, Jariyakosol S, Apinyawasisuk S, Rattanapinyopituk K, Chariyavilaskul P, Meesilpavikkai K, Chongpison Y.   +6 more
europepmc   +1 more source

Nasal Air‐Jet Sensitivity Differentiates Empty Nose Syndrome and Turbinate Reduction Patients: A Pilot Study

The Laryngoscope, EarlyView.
This prospective pilot study aims to compare nasal mucosal sensitivity to air‐jet stimuli between ENS patients and patients who underwent septoplasty/turbinate reduction (septo‐turb) surgery, but without ENS symptoms. The ENS group had a significantly higher (less sensitive) threshold than the septo‐turb group for the septum opposing the center of the ...
Kanghyun Kim, Ahmad Odeh, Jack Harness, Nidhi Jha, Veronica Formanek, Joseph Lee, Bradley Otto, Kathleen Kelly, Kai Zhao   +8 more
wiley   +1 more source

Characteristics of Patients with Dry Eye Who Switched from Long-Acting Ophthalmic Solution to Diquafosol Ophthalmic Solution. [PDF]

J Clin Med
Ishikawa S, Maruyama T, Murayama K, Shinoda K.   +3 more
europepmc   +1 more source

The Automated Vestibular Rehabilitation System: Normative Data From a Machine Vision‐Guided Platform

The Laryngoscope, EarlyView.
The Automated Vestibular Rehabilitation System (AVRS) is a machine vision‐based tool designed to increase accessibility to vestibular rehabilitation therapy by automating exercise delivery and tracking head‐eye movements in real time. In n = 40 healthy adults, the AVRS accurately measured vestibulo‐ocular reflex (VOR) gain values near physiologic norms
Erin Williams, Felipe Echeverri Tribin, Luis Rodriguez Diaz, Valerie Yunis, Devin Kennedy, Blaine Ayotte, Christopher McKenna, Odile Clavier, Michael Hoffer   +8 more
wiley   +1 more source

The Effects of Low Viscosity Preservative-Free Chloroprocaine Ophthalmic Gel 3% versus BAK-Containing Tetracaine 0.5% on the Bactericidal Action of Povidone-Iodine

Clinical Ophthalmology
Haroon Ilyas,1 Richard Costine2 1Brandon Eye Associates, Brandon, FL, 33511, USA; 2Harrow, Nashville, TN, 37205, USACorrespondence: Richard Costine, Harrow, Nashville, TN, 37205, USA, Email rcostine@harrowinc.comPurpose: To evaluate if chloroprocaine ...
Ilyas H, Costine R
doaj  

A Clinical Evaluation of Lifitegrast Ophthalmic Solution 5% in Symptomatic Contact Lens Wearers. [PDF]

Clin Ophthalmol
Schulze MM, Guthrie SE, Ho B, Woods J, Jones L.   +4 more
europepmc   +1 more source

Ex Vivo Evaluation of Poly(Solketal Acrylate) Nanoparticles for Intravitreal Drug Delivery to the Posterior Eye Segment

Macromolecular Rapid Communications, EarlyView.
Nile Red‐loaded poly(solketal acrylate) nanoparticles enable fluorescence tracking and exhibit nontoxic profiles in retinal cells. Enhanced cellular uptake and deep retinal penetration after intravitreal injection highlight their excellent potential for targeted ocular drug delivery to the posterior segment of the eye.
Yasaman Pourdakheli Hamedani, José Hurst, Malte Ritter, Philipp Weingarten, Julia Skokowa, Sven Schnichels, Friederike Adams   +6 more
wiley   +1 more source

Not Just Pink Eye: Allergic Contact Dermatitis to Alcaftadine 0.25% Ophthalmic Solution. [PDF]

Contact Dermatitis
Betancourt Ponce M, Reeder M.
europepmc   +1 more source